Acute lung injury

A clinical and molecular review

Yasmeen Butt, Anna Kurdowska, Timothy Craig Allen

Research output: Contribution to journalReview article

94 Citations (Scopus)

Abstract

Context.-Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are a continuum of lung changes arising from a wide variety of lung injuries, frequently resulting in significant morbidity and frequently in death. Research regarding the molecular pathophysiology of ALI/ ARDS is ongoing, with the aim toward developing prognostic molecular biomarkers and molecular-based therapy. Objective.-To review the clinical, radiologic, and pathologic features of ALI/ARDS; and the molecular pathophysiology of ALI/ARDS, with consideration of possible predictive/prognostic molecular biomarkers and possible molecular-based therapies. Data Sources.-Examination of the English-language medical literature regarding ALI and ARDS. Conclusions.-ARDS is primarily a clinicoradiologic diagnosis; however, lung biopsy plays an important diagnostic role in certain cases. A significant amount of progress has been made in the elucidation of ARDS pathophysiology and in predicting patient response, however, currently there is no viable predictive molecular biomarkers for predicting the severity of ARDS, or molecular-based ARDS therapies. The proinflammatory cytokines TNF-α (tumor necrosis factor α), interleukin (IL)-1β, IL-6, IL-8, and IL-18 are among the most promising as biomarkers for predicting morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)345-350
Number of pages6
JournalArchives of Pathology and Laboratory Medicine
Volume140
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Acute Lung Injury
Adult Respiratory Distress Syndrome
Biomarkers
Morbidity
Lung
Interleukin-18
Information Storage and Retrieval
Lung Injury
Interleukin-8
Interleukin-1
Interleukin-6
Language
Therapeutics
Tumor Necrosis Factor-alpha
Cytokines
Biopsy
Mortality

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Acute lung injury : A clinical and molecular review. / Butt, Yasmeen; Kurdowska, Anna; Allen, Timothy Craig.

In: Archives of Pathology and Laboratory Medicine, Vol. 140, No. 4, 01.04.2016, p. 345-350.

Research output: Contribution to journalReview article

Butt, Yasmeen ; Kurdowska, Anna ; Allen, Timothy Craig. / Acute lung injury : A clinical and molecular review. In: Archives of Pathology and Laboratory Medicine. 2016 ; Vol. 140, No. 4. pp. 345-350.
@article{4b0e97a5a8474bcfb88808c1de9c3478,
title = "Acute lung injury: A clinical and molecular review",
abstract = "Context.-Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are a continuum of lung changes arising from a wide variety of lung injuries, frequently resulting in significant morbidity and frequently in death. Research regarding the molecular pathophysiology of ALI/ ARDS is ongoing, with the aim toward developing prognostic molecular biomarkers and molecular-based therapy. Objective.-To review the clinical, radiologic, and pathologic features of ALI/ARDS; and the molecular pathophysiology of ALI/ARDS, with consideration of possible predictive/prognostic molecular biomarkers and possible molecular-based therapies. Data Sources.-Examination of the English-language medical literature regarding ALI and ARDS. Conclusions.-ARDS is primarily a clinicoradiologic diagnosis; however, lung biopsy plays an important diagnostic role in certain cases. A significant amount of progress has been made in the elucidation of ARDS pathophysiology and in predicting patient response, however, currently there is no viable predictive molecular biomarkers for predicting the severity of ARDS, or molecular-based ARDS therapies. The proinflammatory cytokines TNF-α (tumor necrosis factor α), interleukin (IL)-1β, IL-6, IL-8, and IL-18 are among the most promising as biomarkers for predicting morbidity and mortality.",
author = "Yasmeen Butt and Anna Kurdowska and Allen, {Timothy Craig}",
year = "2016",
month = "4",
day = "1",
doi = "10.5858/arpa.2015-0519-RA",
language = "English (US)",
volume = "140",
pages = "345--350",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

TY - JOUR

T1 - Acute lung injury

T2 - A clinical and molecular review

AU - Butt, Yasmeen

AU - Kurdowska, Anna

AU - Allen, Timothy Craig

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Context.-Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are a continuum of lung changes arising from a wide variety of lung injuries, frequently resulting in significant morbidity and frequently in death. Research regarding the molecular pathophysiology of ALI/ ARDS is ongoing, with the aim toward developing prognostic molecular biomarkers and molecular-based therapy. Objective.-To review the clinical, radiologic, and pathologic features of ALI/ARDS; and the molecular pathophysiology of ALI/ARDS, with consideration of possible predictive/prognostic molecular biomarkers and possible molecular-based therapies. Data Sources.-Examination of the English-language medical literature regarding ALI and ARDS. Conclusions.-ARDS is primarily a clinicoradiologic diagnosis; however, lung biopsy plays an important diagnostic role in certain cases. A significant amount of progress has been made in the elucidation of ARDS pathophysiology and in predicting patient response, however, currently there is no viable predictive molecular biomarkers for predicting the severity of ARDS, or molecular-based ARDS therapies. The proinflammatory cytokines TNF-α (tumor necrosis factor α), interleukin (IL)-1β, IL-6, IL-8, and IL-18 are among the most promising as biomarkers for predicting morbidity and mortality.

AB - Context.-Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are a continuum of lung changes arising from a wide variety of lung injuries, frequently resulting in significant morbidity and frequently in death. Research regarding the molecular pathophysiology of ALI/ ARDS is ongoing, with the aim toward developing prognostic molecular biomarkers and molecular-based therapy. Objective.-To review the clinical, radiologic, and pathologic features of ALI/ARDS; and the molecular pathophysiology of ALI/ARDS, with consideration of possible predictive/prognostic molecular biomarkers and possible molecular-based therapies. Data Sources.-Examination of the English-language medical literature regarding ALI and ARDS. Conclusions.-ARDS is primarily a clinicoradiologic diagnosis; however, lung biopsy plays an important diagnostic role in certain cases. A significant amount of progress has been made in the elucidation of ARDS pathophysiology and in predicting patient response, however, currently there is no viable predictive molecular biomarkers for predicting the severity of ARDS, or molecular-based ARDS therapies. The proinflammatory cytokines TNF-α (tumor necrosis factor α), interleukin (IL)-1β, IL-6, IL-8, and IL-18 are among the most promising as biomarkers for predicting morbidity and mortality.

UR - http://www.scopus.com/inward/record.url?scp=84964047913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964047913&partnerID=8YFLogxK

U2 - 10.5858/arpa.2015-0519-RA

DO - 10.5858/arpa.2015-0519-RA

M3 - Review article

VL - 140

SP - 345

EP - 350

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -